Form 4: Harvard Apparatus Regenerative Technology Director, Ting Li, Acquires Stock Options
SEC Form 4
Director Ting Li acquired stock options in Harvard Apparatus Regenerative Technology, Inc. on June 27, 2024.
Summary
- Ting Li, a director of Harvard Apparatus Regenerative Technology, Inc. (HRGN), acquired stock options on June 27, 2024.
- Li acquired 10,204 stock options at an exercise price of $2.92, which vest in four equal installments on September 27, 2024, December 27, 2024, March 27, 2025 and June 27, 2025.
- Li also acquired 8,215 stock options at an exercise price of $2.92, which vest in four equal installments on June 27, 2024, June 30, 2024, September 30, 2024 and December 31, 2024.
- These options were granted as part of the annual equity grant and in lieu of cash compensation for Li's role as a non-employee director.
- Following the transaction, Li directly owns 10,204 and 8,215 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it reflects a standard transaction of stock option grants to a director. It doesn't inherently indicate positive or negative performance, but rather a routine part of director compensation.
Positives
- The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This filing is a routine disclosure related to director compensation and equity ownership, common in publicly traded companies.
Stakeholder Impact
- The granting of stock options aligns the director's interests with those of the shareholders, potentially encouraging decisions that increase shareholder value.
Key Dates
| Date | Description |
|---|---|
| 06/27/2024 | Date of earliest transaction and grant date for stock options. |
| 06/30/2024 | First vesting date for 8,215 stock options granted in lieu of cash compensation. |
| 07/15/2024 | Date of signature for the Form 4 filing. |
| 09/27/2024 | First vesting date for 10,204 stock options granted as annual equity. |
| 09/30/2024 | Second vesting date for 8,215 stock options granted in lieu of cash compensation. |
| 12/27/2024 | Second vesting date for 10,204 stock options granted as annual equity. |
| 12/31/2024 | Third vesting date for 8,215 stock options granted in lieu of cash compensation. |
| 03/27/2025 | Third vesting date for 10,204 stock options granted as annual equity. |
| 06/27/2025 | Final vesting date for 10,204 stock options granted as annual equity. |
| 06/27/2034 | Expiration date for both stock option grants. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.